World's Best Scientists 2026 revealed!
Sean V. Tavtigian

Sean V. Tavtigian

D-Index & Metrics

Genetics

D-Index
81
Citations
52215
World Ranking
1490
National Ranking
697

Medicine

D-Index
81
Citations
52424
World Ranking
16363
National Ranking
8231

Sean V. Tavtigian publication distribution in Genetics in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Genetics in 2026. The highlighted bar marks where Sean V. Tavtigian sits on this spectrum.

45–54 publications: 6 scientists 55–64 publications: 10 scientists 65–74 publications: 35 scientists 75–84 publications: 84 scientists 85–94 publications: 102 scientists 95–104 publications: 151 scientists 105–114 publications: 175 scientists 115–124 publications: 203 scientists 125–134 publications: 217 scientists 135–144 publications: 205 scientists 145–154 publications: 193 scientists 155–164 publications: 188 scientists 165–174 publications: 170 scientists 175–184 publications: 178 scientists 185–194 publications: 164 scientists 195–204 publications: 173 scientists 205–214 publications: 159 scientists 215–224 publications: 134 scientists 225–234 publications: 143 scientists 235–244 publications: 105 scientists 245–254 publications: 114 scientists 255–264 publications: 92 scientists 265–274 publications: 88 scientists 275–284 publications: 87 scientists 285–294 publications: 80 scientists 295–304 publications: 62 scientists 305–314 publications: 75 scientists 315–324 publications: 67 scientists 325–334 publications: 60 scientists 335–344 publications: 52 scientists 345–354 publications: 40 scientists 355–364 publications: 48 scientists 365–374 publications: 47 scientists 375–384 publications: 46 scientists 385–394 publications: 31 scientists 395–404 publications: 27 scientists 405–414 publications: 40 scientists 415–424 publications: 30 scientists 425–434 publications: 43 scientists 435–444 publications: 29 scientists 445–454 publications: 14 scientists 455–464 publications: 28 scientists 465–474 publications: 21 scientists 475–484 publications: 21 scientists 485–494 publications: 22 scientists 495–504 publications: 17 scientists 505–514 publications: 12 scientists 515–524 publications: 11 scientists 525–534 publications: 8 scientists 535–544 publications: 8 scientists 545–554 publications: 14 scientists 555–564 publications: 4 scientists 565–574 publications: 11 scientists 575–584 publications: 5 scientists 585–594 publications: 11 scientists 595–604 publications: 12 scientists 605–614 publications: 7 scientists 615–624 publications: 6 scientists 625–634 publications: 10 scientists 635–644 publications: 9 scientists 645–654 publications: 10 scientists 655–664 publications: 6 scientists 665–674 publications: 6 scientists 675–684 publications: 6 scientists 685–694 publications: 4 scientists 695–702 publications: 6 scientists 703+ publications: 100 scientists
45 publications 703+

This scientist: 243 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 703 publications or more.

Sean V. Tavtigian D-index placement in Genetics in 2026

The chart shows the D-index (discipline H-index) distribution of Genetics scientists ranked by Research.com in 2026. The highlighted bar marks where Sean V. Tavtigian sits on this spectrum.

40–41 D-Index: 24 scientists 42–43 D-Index: 52 scientists 44–45 D-Index: 84 scientists 46–47 D-Index: 112 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 141 scientists 52–53 D-Index: 143 scientists 54–55 D-Index: 145 scientists 56–57 D-Index: 179 scientists 58–59 D-Index: 162 scientists 60–61 D-Index: 175 scientists 62–63 D-Index: 191 scientists 64–65 D-Index: 172 scientists 66–67 D-Index: 184 scientists 68–69 D-Index: 164 scientists 70–71 D-Index: 158 scientists 72–73 D-Index: 150 scientists 74–75 D-Index: 136 scientists 76–77 D-Index: 127 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 111 scientists 82–83 D-Index: 110 scientists 84–85 D-Index: 110 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 102 scientists 90–91 D-Index: 66 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 70 scientists 96–97 D-Index: 54 scientists 98–99 D-Index: 60 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 55 scientists 104–105 D-Index: 45 scientists 106–107 D-Index: 42 scientists 108–109 D-Index: 28 scientists 110–111 D-Index: 39 scientists 112–113 D-Index: 25 scientists 114–115 D-Index: 31 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 34 scientists 120–121 D-Index: 29 scientists 122–123 D-Index: 29 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 27 scientists 128–129 D-Index: 22 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 11 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 21 scientists 140–141 D-Index: 4 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 14 scientists 146–147 D-Index: 6 scientists 148–149 D-Index: 10 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 9 scientists 154–155 D-Index: 8 scientists 156–157 D-Index: 8 scientists 158–159 D-Index: 9 scientists 160+ D-Index: 96 scientists
40 D-Index 160+

This scientist: 81 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 160 D-Index or more.

Overview

Sean V. Tavtigian is affiliated with the University of Utah in the United States and has a scholarly focus in the fields of Biochemistry, Genetics, and Molecular Biology, with a significant body of work spanning 101 publications. They have also contributed extensively to Medicine, with 41 publications noted. Their research covers various subfields, including Genetics, Molecular Biology, Pathology and Forensic Medicine, Cancer Research, and Oncology.

The scientist's research topics reflect a concentration on genetic factors affecting health and disease. Frequent topics include Genomics and Rare Diseases, Genetic factors in colorectal cancer, BRCA gene mutations in cancer, Cancer Genomics and Diagnostics, Genetic Associations and Epidemiology, Genomic variations and chromosomal abnormalities, and CRISPR and Genetic Engineering.

Sean V. Tavtigian has published frequently in venues such as bioRxiv (Cold Spring Harbor Laboratory), The American Journal of Human Genetics, Genetics in Medicine Open, Genetics in Medicine, and Human Mutation. These publications collectively indicate strong engagement with genetics and clinical genomics communities.

Significant recent papers illustrating their contributions include:

  • Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel, 2024, The American Journal of Human Genetics
  • Using the ACMG/AMP framework to capture evidence related to predicted and observed impact on splicing: Recommendations from the ClinGen SVI Splicing Subgroup, 2023, The American Journal of Human Genetics
  • Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria, 2022, The American Journal of Human Genetics
  • Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (PERSPECTIVE I&I), 2021, Journal of Personalized Medicine
  • Fitting a naturally scaled point system to the ACMG/AMP variant classification guidelines, 2020, Human Mutation

Collaborative work is a notable aspect of their career, with frequent co-authors including Tina Pesaran, Marc S. Greenblatt, Amanda B. Spurdle, Steven M. Harrison, and Leslie G. Biesecker. These collaborations suggest a network centered on genetic variant interpretation and clinical genomics.

Best Publications

  • A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

    Yoshio Miki;Jeff Swensen;Donna Shattuck-Eidens;P. Andrew Futreal

  • A cell cycle regulator potentially involved in genesis of many tumor types

    Alexander Kamb;Nelleke A. Gruis;Jane Weaver-Feldhaus;Qingyun Liu

  • A draft sequence of the rice genome (Oryza sativa L. ssp indica)

    Stephen A. Goff;Darrell Ricke;Tien-Hung Lan;Gernot Presting

  • Identification of a candidate tumour suppressor gene, MMAC1 , at chromosome 10q23.3 that is mutated in multiple advanced cancers

    P. A. Steck;M. A. Pershouse;S. A. Jasser;W. K. A. Yung

  • Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database.

    Audrey Petitjean;Ewy Mathe;Ewy Mathe;Shunsuke Kato;Chikashi Ishioka

  • Whole-Genome Shotgun Assembly and Analysis of the Genome of Fugu rubripes

    Samuel Aparicio;Jarrod Chapman;Elia Stupka;Nik Putnam

  • BRCA1 mutations in primary breast and ovarian carcinomas

    P. Andrew Futreal;Qingyun Liu;Donna Shattuck-Eidens;Charles Cochran

  • The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds.

    S.V. Tavtigian;J. Simard;J. Rommens;F. Couch

  • Clinical Characteristics of Individuals With Germline Mutations in BRCA1 and BRCA2: Analysis of 10,000 Individuals

    Thomas S. Frank;Amie M. Deffenbaugh;Julia E. Reid;Mark Hulick

  • Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk

    Douglas Frederick Easton;Paul David Pharoah;Antonis C. Antoniou;Marc Derek Tischkowitz

  • Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results

    Sharon E. Plon;Diana M. Eccles;Douglas Easton;William D. Foulkes

  • Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral

    Sean V Tavtigian;Amie M Deffenbaugh;Luo Yin;Thaddeus Judkins

  • A candidate prostate cancer susceptibility gene at chromosome 17p.

    Sean V. Tavtigian;Jacques Simard;David H F Teng;Vicki Abtin

  • RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2.

    Alexander K.C. Wong;Ralph Pero;Patricia A. Ormonde;Sean V. Tavtigian

  • A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes.

    Steinunn Thorlacius;Gudridur Olafsdottir;Laufey Tryggvadottir;Susan Neuhausen

  • Complex Structure and Regulation of the P16 (MTS1) Locus

    Steven Stone;Ping Jiang;Priya Dayananth;Sean V. Tavtigian

  • Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2.

    David E. Goldgar;Douglas F. Easton;Amie M. Deffenbaugh;Alvaro N.A. Monteiro

  • A Systematic Genetic Assessment of 1,433 Sequence Variants of Unknown Clinical Significance in the BRCA1 and BRCA2 Breast Cancer–Predisposition Genes

    Douglas F. Easton;Amie M. Deffenbaugh;Dmitry Pruss;Cynthia Frye

  • BRCA1 Sequence Analysis in Women at High Risk for Susceptibility Mutations: Risk Factor Analysis and Implications for Genetic Testing

    Donna Shattuck-Eidens;Arnold Oliphant;Melody McClure;Celeste McBride

  • Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database

    Bryony A Thompson;Bryony A Thompson;Amanda B Spurdle;John-Paul Plazzer;Marc S Greenblatt

Frequent Co-Authors

David E. Goldgar
David E. Goldgar University of Utah
Mark H. Skolnick
Mark H. Skolnick Myriad Genetics (Germany)
Amanda B. Spurdle
Amanda B. Spurdle QIMR Berghofer Medical Research Institute
Lisa A. Cannon-Albright
Lisa A. Cannon-Albright University of Utah
Melissa C. Southey
Melissa C. Southey Monash University
Esther M. John
Esther M. John Stanford University
Fergus J. Couch
Fergus J. Couch Mayo Clinic
John L. Hopper
John L. Hopper University of Melbourne
Georgia Chenevix-Trench
Georgia Chenevix-Trench QIMR Berghofer Medical Research Institute
Irene L. Andrulis
Irene L. Andrulis University of Toronto

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Genetics opens doors to a variety of career pathways in healthcare and life sciences. Many students consider related online programs to broaden their expertise or find entry points into the field. For instance, those interested in medical records may look into how much does it cost to become a medical billing and coding professional, as this is a role with increasing demand in both clinical and research settings.

Others may prefer direct patient care and seek out the easiest nursing program to get into, which can provide foundational medical knowledge that's valuable in genetics counseling and support roles.

If you're interested in healthcare leadership, exploring healthcare administration degree programs can equip you with essential management skills. Many students also prioritize affordability, making the most affordable healthcare administration degrees online an attractive option.

Whether you're passionate about hands-on patient care, medical data, or healthcare operations, there are diverse online degrees that align with genetics and can expand your career opportunities in the growing medical sector.

Best Scientists Citing Sean V. Tavtigian

Trending Scientists

Recently Published Articles